Literature DB >> 2517783

Health outcome models for policy analysis.

R M Kaplan1.   

Abstract

The increasing therapeutic options in health care have created new dilemmas because resources to pay for the new technologies are limited. Cost/effectiveness and cost/utility models are required in order to evaluate the return on the invested dollar for various health care technologies. The problem is that different technologies are often evaluated using very different outcome units. The alternatives may range from liver transplantation to rehabilitation to preventive care. This article presents an overview of a general health policy model that expresses the benefits of all programs in a common unit known as the well-year--defined as the equivalent of 1 completely well year of life. The model uses two data sources: life expectancy and health-related quality of life during years prior to death. The quality-of-life component considers behavioral scales for mobility, physical activity, social activity, and symptoms. These dimensions are weighted by utility or preference to create a single scale that ranges from 0 (for death) for 1.0 (for optimum health). The model also considers duration of stay in each health state. Because all providers in health care attempt to extend life expectancy and improve quality of life, very different approaches in health care can be evaluated against one another. Preliminary analyses suggest that some behavioral interventions compete favorably with traditional medical and surgical treatments in terms of cost/well-year of life production. Various applications of the model are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2517783

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  7 in total

1.  Positive and negative affect in rheumatoid arthritis: Increased specificity in the assessment of emotional adjustment.

Authors:  T W Smith; A J Christensen
Journal:  Ann Behav Med       Date:  1996-06

2.  Involvement in decision-making about treatment and ovarian cancer survivor quality of life.

Authors:  M Robyn Andersen; Erin Sweet; Kimberly A Lowe; Leanna J Standish; Charles W Drescher; Barbara A Goff
Journal:  Gynecol Oncol       Date:  2011-10-29       Impact factor: 5.482

Review 3.  Generic health-related quality-of-life assessment in children and adolescents: methodological considerations.

Authors:  Ulrike Ravens-Sieberer; Michael Erhart; Nora Wille; Ralf Wetzel; Jennifer Nickel; Monika Bullinger
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Associations Between Smoking Status and Physical and Mental Health-Related Quality of Life Among Individuals With Mobility Impairments.

Authors:  Romano Endrighi; Yihong Zhao; Rosemary B Hughes; Deepak Kumar; Belinda Borrelli
Journal:  Ann Behav Med       Date:  2022-08-30

Review 5.  Patient-reported outcomes in cystic fibrosis.

Authors:  Christopher H Goss; Alexandra L Quittner
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

6.  Empirically defined health states for depression from the SF-12.

Authors:  C A Sugar; R Sturm; T T Lee; C D Sherbourne; R A Olshen; K B Wells; L A Lenert
Journal:  Health Serv Res       Date:  1998-10       Impact factor: 3.402

Review 7.  Patient preferences for the treatment of type 2 diabetes: a scoping review.

Authors:  Susan M Joy; Emily Little; Nisa M Maruthur; Tanjala S Purnell; John F P Bridges
Journal:  Pharmacoeconomics       Date:  2013-10       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.